“Giant Exit: NeuroDerm is Sold for $1.1B”

Adv. Ido Zemach, partner in the International Corporate and Securities Department, represented Mitsubishi Tanabe Pharma Corporation in this significant transaction.
https://www.themarker.com/markets/1.4282397